Sono-Tek (NASDAQ: SOTK) lands $5M medical device coating order contract

Rhea-AI Filing Summary

Sono-Tek Corporation reported that it issued a press release announcing an order for medical device coating systems valued at over $5 million. The company described this order in a report about its results of operations and financial condition and as a Regulation FD disclosure.

The press release, dated September 3, 2025 and attached as an exhibit, provides additional details on the order. The information in this report and the exhibit is being furnished rather than filed, meaning it is not subject to certain liability provisions of the securities laws or automatically incorporated into other company reports.

8-K Event Classification

3 items: 2.02, 7.01, 9.01

3 items

Item 2.02 Results of Operations and Financial Condition Financial

Disclosure of earnings results, typically an earnings press release or preliminary financials.

Item 7.01 Regulation FD Disclosure Disclosure

Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, and exhibit attachments filed with this report.

Understanding 8-K Material Events →

false 0000806172 SONO TEK CORP 0000806172 2025-09-03 2025-09-03 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): September 3, 2025

Sono-Tek Corporation

(Exact name of registrant as specified in its charter)

Commission File Number: 001-40763

New York		14-1568099
(State of Incorporation)		(I.R.S. Employer ID No.)
2012 Route 9W, Milton, New York		12547
(Address of Principal Executive Offices)		(Zip Code)

Registrant’s telephone number, including area code: (845) 795-2020

Check appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, $0.01 par value per share	SOTK	NASDAQ

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02: Results of Operations and Financial Condition.

Item 7.01: Regulation FD Disclosure

On September 3, 2025, Sono-Tek Corporation issued a press regarding an order for medical device coating systems valued at over $5 Million which is attached as exhibit 99.1.

The information furnished pursuant to Item 2.02 and Item 7.01, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities under such section and shall not be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act.

Item 9.01: Financial Statements and Exhibits.

(d) Exhibits

99.1       Press release dated September 3, 2025

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

SONO-TEK CORPORATION

By: /s/ Stephen J. Bagley

Stephen J. Bagley

Chief Financial Officer

September 3, 2025

FAQ

What did Sono-Tek (SOTK) disclose in this 8-K report?

Sono-Tek disclosed that it issued a press release announcing an order for medical device coating systems valued at over $5 million.

What is the value of the new order Sono-Tek received?

The order for medical device coating systems is valued at over $5 million.

Does this Sono-Tek (SOTK) 8-K include full financial results?

No detailed financial statements are included in the text provided; the report focuses on an order for medical device coating systems and references a related press release.

How is the information in Sono-Tek’s report treated under securities laws?

The information under Items 2.02 and 7.01, including the press release, is being furnished, not filed, so it is not subject to certain liability provisions and is not automatically incorporated into other reports.

When was the Sono-Tek press release about the $5 million order issued?

The press release describing the order is dated September 3, 2025.

What exhibit is attached to Sono-Tek’s 8-K related to this order?

Exhibit 99.1 is attached, consisting of the press release dated September 3, 2025.